14662 results for "PLOS+ONE+Pennsylvania+German+ACS+language+code+pdc+open+access+study"

in 46.09 milliseconds.

• NeuroCoV Data Access Committee

  Dac EGAC00001002776

• Radarstudy Data Access Committee

  Dac EGAC00001003289

• Hubrecht Institute Data Access Commitee

  Dac EGAC00001003003

• SECRETO Oral Data Access Committee

  Dac EGAC00001003449

• Sottorivalab data access committee

  Dac EGAC00001003184

• DIPG THU Data Access Committee

  Dac EGAC00001002169

• EPIC Repeatability Data Access Committee

  Dac EGAC00001003201

• NSCLC Team Data Access Committee

  Dac EGAC00001002258

• DFCI cHL Data Access Commitee

  Dac EGAC00001003432

• Human Heart Data Access Committee

  Dac EGAC50000000413

• Beggs Lab Data Access Committee

  Dac EGAC00001001819

• Inform-Lynch-Syndrome-Access

  Dac EGAC00001003315

• EMBARCAM BC360 PROJECT Data Access Committee

  Dac EGAC00001003517

• Personalis, Inc. Data Access Committee

  Dac EGAC50000000325

• BIOCLOCK Data Access Committee

  Dac EGAC00001003573

• BIDMC Proteogenomics Data Access Committee

  Dac EGAC50000000386

• Urothelial Cancer - Genomic Analysis to Improve Patient Outcomes and Research (UC-GENOME): A Bladder Cancer Advocacy Network (BCAN)-Led Collaborative Research Pilot Study

  UC-GENOME is a real-world cohort of patients with metastatic urothelial carcinoma (UC). The study consisted of two co-equal aims: 1) to provide targeted DNA sequencing for clinical decision making at no cost to patients; and 2) to create a resource for collaborative translational science including a clinically annotated biobank. The submitted data represents the foundational analysis of 218 patients accrued at 7 academic medical centers. The analysis includes 176 patients with both targeted DNA sequencing and RNA sequencing. The genomic data was combined with clinical variables to model response to chemotherapy and immune checkpoint inhibitors (ICI). Due to additional sharing restrictions, data from one site can be found in phs003094.

  Study phs003066

• Targeted sequencing of cell-free DNA and white blood cells from 24 men with metastatic prostate cancer

  This dataset consists of aligned DNA sequencing data in BAM file format from cell-free DNA and white blood cells from 24 men with metastatic prostate cancer. One cell-free DNA sample and one white blood cell sample is available for each patient, resulting in 48 total BAM files in this dataset. The sequencing was performed using a hybrid capture-based targeted panel of 73 prostate cancer driver genes.

  Dataset EGAD00001004486

• Patient-derived neuroblastoma model system OHC-NB1

  The dataset is comprised of seven samples, one blood sample (germline control) of the patient, one neuroblastoma metastasis from the bone marrow and five derived cell models. The models include the primary culture, the first xenogenograft passage, a monolayer culture derived from the first xenograft passage and two samples of the fourth xenograft passage, cells and supernatant. For all these samples, whole-exome sequencing data have been generated. The BAM files contain the alignments against the human genome, assembly GRCh37, and also the unaligned reads.

  Dataset EGAD00001004138

• Multi-region sequencing of 10 neuroblastoma cases

  To investigate intratumour heterogeneity and to better understand tumour evolution in neuroblastoma, we have performed a multi-region whole-exome sequencing on a total of 51 spatially separated tumor samples from 9 primary neuroblastomas (2 low-risk, 1 intermediate-risk and 6 high-risk) and 1 relapsed neuroblastoma. We also assessed the impact of chemotherapy on the clonal expansion by sequencing tumour regions from one medium risk and one high-risk tumour for which we had matched samples obtained at diagnosis and after chemotherapy.

  Dataset EGAD00001008020

• Multiple myeloma follow-up Dataset

  77 samples collected from 35 multiple myeloma patients. Each patient provided one healthy sample and one primary tumor sample and, in some cases, also samples collected after the progression of the disease.

  Dataset EGAD00001010161

• DAC for Cornell-NCI DLBCL NGS Genomic Project

  Genome-wide sequencing experiments were conducted on 103 DLBCL biopsy samples, of which the datasets (called Cornell-NCI DLBCL cohort) are available for authorized scientists. The Center of Technology Licensing at Cornell University is in charge of this data access policy and approval. Particularly, Cornell University will email a DAA to each requestor to have their institution sign before access is granted

  Dac EGAC50000000704

• MALT1 in MCL data access commitee

  Dac EGAC00001002989

• MX Biobank Data Access Committee

  Dac EGAC00001002413

• VIB-UZL Data Access Committee

  Dac EGAC00001003377